Probiotic Use in Horses - What is the Evidence for Their Clinical Efficacy?

Journal of Veterinary Internal Medicine

Volumn 28, Issue 6, 2014, Pages 1640-1652

  Schoster, A ^a,b   Weese, J S ^c   Guardabassi, L ^b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF GUELPH   (Canada)

Author keywords

Lactobacillus; Bifidobacterium; Fecal microbial transfaunation; Microbiota

Indexed keywords

BIFIDOBACTERIUM; EQUIDAE; LACTOBACILLUS;

PROBIOTIC AGENT;

ANIMAL; DRUG EFFECTS; GASTROINTESTINAL TRACT; HORSE; HORSE DISEASES; MICROBIOLOGY; MICROFLORA;

ANIMALS; GASTROINTESTINAL TRACT; HORSE DISEASES; HORSES; MICROBIOTA; PROBIOTICS;

EID: 84911461431     PISSN: 08916640     EISSN: 19391676     Source Type: Journal    
DOI: 10.1111/jvim.12451     Document Type: Review

References (99)

1. Lederberg JM, McCray A. Ome Sweet. The Scientist 2001;15:8.
2. Group NHW, Peterson J, Garges S, et al. The NIH Human Microbiome Project. Genome Res 2009;19:2317-2323.
3. Al Jassim RA, Andrews FM. The bacterial community of the horse gastrointestinal tract and its relation to fermentative acidosis, laminitis, colic, and stomach ulcers. The Veterinary clinics of North America. Equine Pract 2009;25:199-215.
4. Costa MC, Arroyo LG, Allen-Vercoe E, et al. Comparison of the fecal microbiota of healthy horses and horses with colitis by high throughput sequencing of the V3-V5 region of the 16S rRNA gene. PLoS ONE 2012;7:e41484.
5. Costa MC, Weese JS. The equine intestinal microbiome. Animal health research reviews/Conference of Research Workers in Animal Diseases 2012: 1-8.
6. Friedrich MJ. Microbiome project seeks to understand human body's microscopic residents. J Am Med Assoc 2008;300:777-778.
7. Frank DN, St Amand AL, Feldman RA, et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 2007;104:13780-13785.
8. Larsen N, Vogensen FK, van den Berg FW, et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS ONE 2010;5:e9085.
9. Wang Z, Klipfell E, Bennett BJ, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 2011;472:57-63.
10. Scher JU, Abramson SB. The microbiome and rheumatoid arthritis. Nat Rev Rheumatol 2011;7:569-578.
11. Baverud V, Franklin A, Gunnarsson A, et al. Clostridium difficile associated with acute colitis in mature horses treated with antibiotics. Equine Vet J 1997;29:279-284.
12. Baverud V, Gustafsson A, Gunnarsson A, et al. The association of erythromycin ethylsuccinate with acute colitis in horses in Sweden. Equine Vet J 1997;29:314-318.
13. Garrett LA, Brown R, Poxton IR. A comparative study of the intestinal microbiota of healthy horses and those suffering from equine grass sickness. Vet Microbiol 2002;87:81-88.
14. Milinovich GJ, Trott DJ, Burrell PC, et al. Fluorescence in situ hybridization analysis of hindgut bacteria associated with the development of equine laminitis. Environ Microbiol 2007;9:2090-2100.
15. Moreau MM, Eades SC, Reinemeyer CR, et al. Illumina sequencing of the V4 hypervariable region 16S rRNA gene reveals extensive changes in bacterial communities in the cecum following carbohydrate oral infusion and development of early-stage acute laminitis in the horse. Vet Microbiol 2014;168:436-441.
16. Bailey SR, Rycroft A, Elliott J. Production of amines in equine cecal contents in an in vitro model of carbohydrate overload. J Anim Sci 2002;80:2656-2662.
17. Medina B, Girard ID, Jacotot E, Julliand V. Effect of a preparation of Saccharomyces cerevisiae on microbial profiles and fermentation patterns in the large intestine of horses fed a high fiber or a high starch diet. J Anim Sci 2002;80:2600-2609.
18. Milinovich GJ, Burrell PC, Pollitt CC, et al. Microbial ecology of the equine hindgut during oligofructose-induced laminitis. ISME J 2008;2:1089-1100.
19. Milinovich GJ, Trott DJ, Burrell PC, et al. Changes in equine hindgut bacterial populations during oligofructose-induced laminitis. Environ Microbiol 2006;8:885-898.
20. Respondek F, Goachet AG, Julliand V. Effects of dietary short-chain fructooligosaccharides on the intestinal microflora of horses subjected to a sudden change in diet. J Anim Sci 2008;86:316-323.
21. Muhonen S, Connysson M, Lindberg JE, et al. Effects of crude protein intake from grass silage-only diets on the equine colon ecosystem after an abrupt feed change. J Anim Sci 2008;86:3465-3472.
22. Muhonen S, Julliand V, Lindberg JE, et al. Effects on the equine colon ecosystem of grass silage and haylage diets after an abrupt change from hay. J Anim Sci 2009;87:2291-2298.
23. Shepherd ML, Swecker WS Jr, Jensen RV, Ponder MA. Characterization of the fecal bacteria communities of forage-fed horses by pyrosequencing of 16S rRNA V4 gene amplicons. FEMS Microbiol Lett 2012;326:62-68.
24. Dougal K, Harris PA, Edwards A, et al. A comparison of the microbiome and the metabolome of different regions of the equine hindgut. FEMS Microbiol Ecol 2012;82:642-652.
25. Dougal K, de la Fuente G, Harris PA, et al. Characterisation of the faecal bacterial community in adult and elderly horses fed a high fibre, high oil or high starch diet using 454 pyrosequencing. PLoS ONE 2014;9:e87424.
26. O' Donnell MM, Harris HM, Jeffery IB, et al. The core faecal bacterial microbiome of Irish Thoroughbred racehorses. Lett Appl Microbiol 2013;57:492-501.
27. Dougal K, de la Fuente G, Harris PA, et al. Identification of a core bacterial community within the large intestine of the horse. PLoS ONE 2013;8:e77660.
28. Schoster A, Arroyo LG, Staempfli HR, Weese JS. Comparison of microbial populations in the small intestine, large intestine and feces of healthy horses using terminal restriction fragment length polymorphism. BMC Res Notes 2013;6:91.
29. Metchnikoff E. Optimistic studies. New York: Putman''s Sons. 1908:22.
30. FAO/WHO. Working group for drafting guidelines for the evaluation of probiotics in food. ftp://ftpfaoorg/es/esn/food/wgreport2pdf 2002.
31. Kailasapathy K, Chin J. Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp. Immunol Cell Biol 2000;78:80-88.
32. Gibson GR, Fuller R. Aspects of in vitro and in vivo research approaches directed toward identifying probiotics and prebiotics for human use. J Nutr 2000;130:391S-395S.
33. Yuki N, Shimazaki T, Kushiro A, et al. Colonization of the stratified squamous epithelium of the nonsecreting area of horse stomach by lactobacilli. Appl Environ Microbiol 2000;66:5030-5034.
34. Laukova A, Simonova M, Strompfova V, et al. Potential of enterococci isolated from horses. Anaerobe 2008;14:234-236.
35. Laukova A, Strompfova V, Ouwehand A. Adhesion properties of enterococci to intestinal mucus of different hosts. Vet Res Commun 2004;28:647-655.
36. Rinkinen M, Westermarck E, Salminen S, Ouwehand AC. Absence of host specificity for in vitro adhesion of probiotic lactic acid bacteria to intestinal mucus. Vet Microbiol 2003;97:55-61.
37. Schoster A, Kokotovic B, Permin A, et al. In vitro inhibition of Clostridium difficile and Clostridium perfringens by commercial probiotic strains. Anaerobe 2013;20:36-41.
38. Gueimonde M, Sanchez B, de los Reyes-Gavilan CG, Margolles A. Antibiotic resistance in probiotic bacteria. Front Microbiol 2013;4:202.
39. Bennedsen M, Stuer-Lauridsen B, Danielsen M, Johansen E. Screening for antimicrobial resistance genes and virulence factors via genome sequencing. Appl Environ Microbiol 2011;77:2785-2787.
40. Cebrian R, Banos A, Valdivia E, et al. Characterization of functional, safety, and probiotic properties of Enterococcus faecalis UGRA10, a new AS-48-producer strain. Food Microbiol 2012;30:59-67.
41. Banwo K, Sanni A, Tan H. Technological properties and probiotic potential of Enterococcus faecium strains isolated from cow milk. J Appl Microbiol 2013;114:229-241.
42. Munoz-Atienza E, Gomez-Sala B, Araujo C, et al. Antimicrobial activity, antibiotic susceptibility and virulence factors of Lactic Acid Bacteria of aquatic origin intended for use as probiotics in aquaculture. BMC Microbiol 2013;13:15.
43. Mater DD, Langella P, Corthier G, Flores MJ. A probiotic Lactobacillus strain can acquire vancomycin resistance during digestive transit in mice. J Mol Microbiol Biotechnol 2008;14:123-127.
44. Tannock GW, Luchansky JB, Miller L, et al. Molecular characterization of a plasmid-borne (pGT633) erythromycin resistance determinant (ermGT) from Lactobacillus reuteri 100-63. Plasmid 1994;31:60-71.
45. Vescovo M, Morelli L, Bottazzi V, Gasson MJ. Conjugal transfer of broad-host-range plasmid pAMbeta1 into enteric species of lactic acid bacteria. Appl Environ Microbiol 1983;46:753-755.
46. Weese JS, Anderson ME, Lowe A, Monteith GJ. Preliminary investigation of the probiotic potential of Lactobacillus rhamnosus strain GG in horses: Fecal recovery following oral administration and safety. Can Vet J 2003;44:299-302.
47. Desrochers AM, Dolente BA, Roy MF, et al. Efficacy of Saccharomyces boulardii for treatment of horses with acute enterocolitis. J Am Vet Med Assoc 2005;227:954-959.
48. Jouany JP, Gobert J, Medina B, et al. Effect of live yeast culture supplementation on apparent digestibility and rate of passage in horses fed a high-fiber or high-starch diet. J Anim Sci 2008;86:339-347.
49. Jouany JP, Medina B, Bertin G, Julliand V. Effect of live yeast culture supplementation on hindgut microbial communities and their polysaccharidase and glycoside hydrolase activities in horses fed a high-fiber or high-starch diet. J Anim Sci 2009;87:2844-2852.
50. van Duijkeren E, Flemming C, Sloet van Oldruitenborgh-Oosterbaan M, et al. Diagnosing salmonellosis in horses. Culturing of multiple versus single faecal samples. Vet Q 1995;17:63-66.
51. Oelschlaeger TA. Mechanisms of probiotic actions - A review. Int J Med Microbiol 2010;300:57-62.
52. Watanabe T, Nishio H, Tanigawa T, et al. Probiotic Lactobacillus casei strain Shirota prevents indomethacin-induced small intestinal injury: Involvement of lactic acid. Am J Physiol Gastrointest Liver Physiol 2009;297:G506-513.
53. de Roock S, van Elk M, van Dijk ME, et al. Lactic acid bacteria differ in their ability to induce functional regulatory T cells in humans. Clin Exp Allergy 2010;40:103-110.
54. Thomas CM, Versalovic J. Probiotics-host communication: Modulation of signaling pathways in the intestine. Gut Microbes 2010;1:148-163.
55. Rinkinen M, Jalava K, Westermarck E, et al. Interaction between probiotic lactic acid bacteria and canine enteric pathogens: A risk factor for intestinal Enterococcus faecium colonization? Vet Microbiol 2003;92:111-119.
56. He B, Xu W, Santini PA, et al. Intestinal bacteria trigger T cell-independent immunoglobulin A(2) class switching by inducing epithelial-cell secretion of the cytokine APRIL. Immunity 2007;26:812-826.
57. Fukushima Y, Kawata Y, Hara H, et al. Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children. Int J Food Microbiol 1998;42:39-44.
58. Park JH, Um JI, Lee BJ, et al. Encapsulated Bifidobacterium bifidum potentiates intestinal IgA production. Cell Immunol 2002;219:22-27.
59. Saarela M, Mogensen G, Fonden R, et al. Probiotic bacteria: Safety, functional and technological properties. J Biotechnol 2000;84:197-215.
60. Collado MC, Grzeskowiak L, Salminen S. Probiotic strains and their combination inhibit in vitro adhesion of pathogens to pig intestinal mucosa. Curr Microbiol 2007;55:260-265.
61. Collado MC, Meriluoto J, Salminen S. Role of commercial probiotic strains against human pathogen adhesion to intestinal mucus. Lett Appl Microbiol 2007;45:454-460.
62. Chen X, Kokkotou EG, Mustafa N, et al. Saccharomyces boulardii inhibits ERK1/2 mitogen-activated protein kinase activation both in vitro and in vivo and protects against Clostridium difficile toxin A-induced enteritis. J Biol Chem 2006;281:24449-24454.
63. Bayoumi MA, Griffiths MW. In vitro inhibition of expression of virulence genes responsible for colonization and systemic spread of enteric pathogens using Bifidobacterium bifidum secreted molecules. Int J Food Microbiol 2012;156:255-263.
64. Allaart JG, van Asten AJ, Vernooij JC, Grone A. Effect of Lactobacillus fermentum on beta2 toxin production by Clostridium perfringens. Appl Environ Microbiol 2011;77:4406-4411.
65. Medellin-Pena MJ, Wang H, Johnson R, et al. Probiotics affect virulence-related gene expression in Escherichia coli O157:H7. Appl Environ Microbiol 2007;73:4259-4267.
66. Castagliuolo I, Riegler MF, Valenick L, et al. Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa. Infect Immun 1999;67:302-307.
67. Gratz S, Taubel M, Juvonen RO, et al. Lactobacillus rhamnosus strain GG modulates intestinal absorption, fecal excretion, and toxicity of aflatoxin B(1) in rats. Appl Environ Microbiol 2006;72:7398-7400.
68. Turner PC, Wu QK, Piekkola S, et al. Lactobacillus rhamnosus strain GG restores alkaline phosphatase activity in differentiating Caco-2 cells dosed with the potent mycotoxin deoxynivalenol. Food Chem Toxicol 2008;46:2118-2123.
69. Weese JS. Evaluation of deficiencies in labeling of commercial probiotics. Can Vet J 2003;44:982-983.
70. Weese JS. Microbiologic evaluation of commercial probiotics. J Am Vet Med Assoc 2002;220:794-797.
71. Weese JS, Martin H. Assessment of commercial probiotic bacterial contents and label accuracy. Can Vet J 2011;52:43-46.
72. Ward MP, Alinovi CA, Couetil LL, et al. A randomized clinical trial using probiotics to prevent Salmonella fecal shedding in hospitalized horses. J Equine Vet Sci 2004;24:242-247.
73. Shanahan F. A commentary on the safety of probiotics. Gastroenterol Clin North Am 2012;41:869-876.
74. Weese JS, Anderson ME, Lowe A, et al. Screening of the equine intestinal microflora for potential probiotic organisms. Equine Vet J 2004;36:351-355.
75. Weese JS, Rousseau J. Evaluation of Lactobacillus pentosus WE7 for prevention of diarrhea in neonatal foals. J Am Vet Med Assoc 2005;226:2031-2034.
76. Parraga ME, Spier SJ, Thurmond M, Hirsh D. A clinical trial of probiotic administration for prevention of Salmonella shedding in the postoperative period in horses with colic. J Vet Intern Med 1997;11:36-41.
77. Boyle AG, Magdesian KG, Durando MM, et al. Saccharomyces boulardii viability and efficacy in horses with antimicrobial-induced diarrhoea. Vet Rec 2013;172:128.
78. Earing E, Bacterial J. Colonization of the equine gut; comparison of mare and foal pairs by PCR-DGGE. Adv Microbiol 2012;02:79-86.
79. Yuyama T. Evaluation of a host-specific Lactobacillus probiotic in neonatal foals. J Appl Res Vet Med 2004;2:26-32. (Yusa S, ed.)
80. Chioukh FZ, Ben Hmida H, Ben Ameur K, et al. [Saccharomyces cerevisiae fungemia in a premature neonate treated receiving probiotics.]. Med Mal Infect 2013;43:359-360.
81. Kim LM, Morley PS, Traub-Dargatz JL, et al. Factors associated with Salmonella shedding among equine colic patients at a veterinary teaching hospital. J Am Vet Med Assoc 2001;218:740-748.
82. Landes AD, Hassel DM, Funk JD, Hill A. Fecal sand clearance is enhanced with a product combining probiotics, prebiotics, and psyllium in clinically normal horses. J Equine Vet Sci 2008;28:79-84.
83. Feary DJ, Hassel DM. Enteritis and colitis in horses. Vet Clin North Am Equine Pract 2006;22:437-479, ix.
84. Frederick J, Giguere S, Sanchez LC. Infectious agents detected in the feces of diarrheic foals: A retrospective study of 233 cases (2003-2008). J Vet Intern Med 2009;23:1254-1260.
85. Vandeplas S, Dubois Dauphin R, Beckers Y, et al. Salmonella in chicken: Current and developing strategies to reduce contamination at farm level. J Food Prot 2010;73:774-785.
86. Frizzo LS, Zbrun MV, Soto LP, et al. Pathogen translocation and histopathological lesions in an experimental model of Salmonella Dublin infection in calves receiving lactic acid bacteria and lactose supplements. J Vet Sci 2012;13:261-270.
87. Ramey DW, Reinertson EL. Sand-induced diarrhea in a foal. J Am Vet Med Assoc 1984;185:537-538.
88. Bertone JJ, Traub-Dargatz JL, Wrigley RW, et al. Diarrhea associated with sand in the gastrointestinal tract of horses. J Am Vet Med Assoc 1988;193:1409-1412.
89. Hart KA, Linnenkohl W, Mayer JR, et al. Medical management of sand enteropathy in 62 horses. Equine Vet J 2012;45:465-469.
90. Arora T, Singh S, Sharma RK. Probiotics: Interaction with gut microbiome and antiobesity potential. Nutrition 2013;29:591-596.
91. Borody TJ, Campbell J. Fecal microbiota transplantation: Current status and future directions. Expert Rev Gastroenterol Hepatol 2011;5:653-655.
92. Gough E, Shaikh H, Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis 2011;53:994-1002.
93. Khoruts A, Dicksved J, Jansson JK, Sadowsky MJ. Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea. J Clin Gastroenterol 2010;44:354-360.
94. Kunde S, Pham A, Bonczyk S, et al. Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis. J Pediatr Gastroenterol Nutr 2013;56:597-601.
95. Bazzocchi G, Gionchetti P, Almerigi PF, et al. Intestinal microflora and oral bacteriotherapy in irritable bowel syndrome. Dig Liver Dis 2002;34(Suppl 2):S48-53.
96. Borody TJ, Warren EF, Leis S, et al. Treatment of ulcerative colitis using fecal bacteriotherapy. J Clin Gastroenterol 2003;37:42-47.
97. Vrieze A, Van Nood E, Holleman F, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 2012;143(913-916):e917.
98. Guo B, Harstall C, Louie T, et al. Systematic review: Faecal transplantation for the treatment of Clostridium difficile-associated disease. Aliment Pharmacol Ther 2012;35:865-875.
99. Grehan MJ, Borody TJ, Leis SM, et al. Durable alteration of the colonic microbiota by the administration of donor fecal flora. J Clin Gastroenterol 2010;44:551-561.